Terms: = Head and neck cancer AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1
30 results:
1. Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review.
Lim I; Tan J; Alam A; Idrees M; Brenan PA; Coletta RD; Kujan O
J Oral Pathol Med; 2024 Feb; 53(2):90-106. PubMed ID: 38316046
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of DNA methylation levels of
Grossi I; Assoni C; Lorini L; Smussi D; Gurizzan C; Grisanti S; Paderno A; Mattavelli D; Piazza C; Pelisenco IA; De Petro G; Salvi A; Bossi P
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38299234
[TBL] [Abstract] [Full Text] [Related]
3. sept9, H4C6, and RASSF1A methylation in nasopharyngeal swabs: A reflection of potential minimally invasive biomarkers for early screening of nasopharyngeal cancer.
Qian T; Zhou Z; Zhang Q; Liou YL; Zhou H
Medicine (Baltimore); 2023 Dec; 102(50):e36583. PubMed ID: 38115290
[TBL] [Abstract] [Full Text] [Related]
4. Circulating Cell-Free sept9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in head and neck Squamous Cell Carcinoma Patients.
Dietrich D; Weider S; de Vos L; Vogt TJ; Färber M; Zarbl R; Hunecke A; Glosch AK; Gabrielpillai J; Bootz F; Bauernfeind FG; Kramer FJ; Kristiansen G; Brossart P; Strieth S; Franzen A
Clin Chem; 2023 Sep; 69(9):1050-1061. PubMed ID: 37477541
[TBL] [Abstract] [Full Text] [Related]
5. Noninvasive Detection of Esophageal cancer by the Combination of msept9 and SNCG.
Zhang L; Yang X; Tian Y; Yu Q; Zhou D; Wu Z; Zhao X
Genet Test Mol Biomarkers; 2022 Jan; 26(1):8-16. PubMed ID: 35089073
[No Abstract] [Full Text] [Related]
6. Maxillary Sinus Floor Infiltration: Results From a Series of 118 Maxillary Sinus cancers.
Arosio AD; Turri-Zanoni M; Sileo G; Tirloni M; Volpi L; Lambertoni A; Margherini S; Mercuri A; Battaglia P; Cherubino M; Castelnuovo P; Bignami M
Laryngoscope; 2022 Jan; 132(1):26-35. PubMed ID: 34156096
[TBL] [Abstract] [Full Text] [Related]
7. circ_sept9, a newly identified circular RNA, promotes oral squamous cell carcinoma progression through miR-1225/PKN2 axis.
Ai Y; Tang Z; Zou C; Wei H; Wu S; Huang D
J Cell Mol Med; 2020 Nov; 24(22):13266-13277. PubMed ID: 33090705
[TBL] [Abstract] [Full Text] [Related]
8. [Prognostic and predictive methylation biomarkers in HNSCC : Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)].
Franzen A; Bootz F; Dietrich D
HNO; 2020 Dec; 68(12):911-915. PubMed ID: 32613323
[TBL] [Abstract] [Full Text] [Related]
9. Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and sept9 DNA Methylation in Blood: An Observational Prospective Study.
de Vos L; Jung M; Koerber RM; Bawden EG; Holderried TAW; Dietrich J; Bootz F; Brossart P; Kristiansen G; Dietrich D
J Mol Diagn; 2020 Jul; 22(7):920-933. PubMed ID: 32361006
[TBL] [Abstract] [Full Text] [Related]
10. sept9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cells.
Jiang Y; Liu L; Xiang Q; He X; Wang Y; Zhou D; Zou C; Chen Q; Peng M; He J; Jiang X; Xiang T; Yang Y
Clin Epigenetics; 2020 Mar; 12(1):41. PubMed ID: 32138771
[TBL] [Abstract] [Full Text] [Related]
11. Potential of quantitative sept9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
[TBL] [Abstract] [Full Text] [Related]
12. Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan.
Pai PC; Chuang CC; Chuang WC; Tsang NM; Tseng CK; Chen KH; Yen TC; Lin CY; Chang KP; Lei KF
Cancer Med; 2018 May; 7(5):1630-1641. PubMed ID: 29608254
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
de Vos L; Gevensleben H; Schröck A; Franzen A; Kristiansen G; Bootz F; Dietrich D
Clin Epigenetics; 2017; 9():125. PubMed ID: 29213339
[TBL] [Abstract] [Full Text] [Related]
14. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of head and neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
[TBL] [Abstract] [Full Text] [Related]
15. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
[TBL] [Abstract] [Full Text] [Related]
16. Promoter hypermethylation of
Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic and prognostic value of SHOX2 and sept9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.
Jung M; Pützer S; Gevensleben H; Meller S; Kristiansen G; Dietrich D
Clin Epigenetics; 2016; 8():24. PubMed ID: 26937257
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
[TBL] [Abstract] [Full Text] [Related]
19. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
[TBL] [Abstract] [Full Text] [Related]
20. Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue.
Connolly D; Hoang HG; Adler E; Tazearslan C; Simmons N; Bernard VV; Castaldi M; Oktay MH; Montagna C
Biol Chem; 2014 Feb; 395(2):157-67. PubMed ID: 24127542
[TBL] [Abstract] [Full Text] [Related]
[Next]
